Takeda doses first subject in Japanese Covid-19 vaccine trial
Takeda Pharmaceutical has dosed the first subject in its Phase I/II study of Novavax’s Covid-19...
Kyowa Kirin reports positive results from atopic dermatitis antibody trial
Speciality pharmaceutical company Kyowa Kirin has reported that the Phase II study of an investigational...
Moderna begins dosing in Covid-19 vaccine study in Japan
Moderna has dosed the first participant in the Phase I/II study of its Covid-19 vaccine...
SanBio publishes interim data from traumatic brain injury trial
The SanBio Group has published the interim analysis data from its Phase II clinical STEM...
Shionogi commences Phase I/II trial of Covid-19 vaccine candidate
Japanese company Shionogi has commenced Phase I/II clinical trial of a prophylactic Covid-19 vaccine candidate...
Senhwa Biosciences enrols first patient in Covid-19 investigational drug trial
Clinical-stage biopharma firm Senhwa Biosciences has enrolled the first patient in a Phase II investigator-initiated...
Does Arcturus’ one-shot Covid-19 vaccine have the potential to match up with leading BioNTech/Pfizer and Moderna candidates?
Leading COVID-19 vaccine candidates from Pfizer/BioNTech (BNT-162b2) and Moderna (mRNA-1273) currently in Phase III trials...
Takeda’s Takhzyro lowers attack rates in hereditary angioedema trial
Takeda has announced final positive results from the Phase III HELP (Hereditary Angioedema Long-term Prophylaxis)...
Japan’s CMIC employs SUSMED trial management system
Japan’s contract research organisation (CRO) CMIC has employed SUSMED’s trial management system to launch its...
Daiichi Sankyo begins oncology therapy trial for metastatic tumours
Daiichi Sankyo has dosed the first patient in a first-in-human global Phase I trial to...